# EBUS-TBNA vs Flex 19G EBUS-TBNA

> **NCT02916459** · NA · UNKNOWN · sponsor: **Heidelberg University** · enrollment: 250 (estimated)

## Conditions studied

- Lymphadenopathy
- Lung Cancer
- Sarcoidosis
- Lymphoma

## Interventions

- **DEVICE:** 21G EBUS-TBNA needle
- **DEVICE:** Flexible 19G EBUS-TBNA needle

## Key facts

- **NCT ID:** NCT02916459
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2018-09
- **Final completion:** 2018-10
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2017-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02916459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02916459, "EBUS-TBNA vs Flex 19G EBUS-TBNA". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02916459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*